Influenza B virus primarily infects humans, causing seasonal epidemics globally. Two
antigenic variants—Victoria-like and Yamagata-like—were detected in the 1980s, of which …

To study the neutralizing epitopes of influenza B virus Victoria group strains, two monoclonal
antibodies (MAbs) were used to select antigenic variants of the virus. MAbs 10B8 and 8E6 …

The antigenic and genetic characteristics of the haemagglutinins of influenza type B viruses
isolated since 1988 during periods of both widespread activity (1990/1991) and sporadic …

To study the neutralizing epitopes of influenza B virus Yamagata group strains, two
monoclonal antibodies (mAbs) were used to select escape mutants of the virus. mAbs 5H4 …

Most structurally characterized broadly neutralizing antibodies (bnAbs) against influenza A
viruses (IAVs) target the conserved conformational epitopes of hemagglutinin (HA). Here, we …

Influenza A and B viruses are responsible for the severe morbidity and mortality worldwide
in annual influenza epidemics. Currently circulating influenza B virus belongs to the …

Influenza A and B viruses can continuously evade humoral immune responses by
developing mutations in the globular head of the hemagglutinin (HA) that prevent antibody …

Influenza B viruses have circulated in humans for over 80 y, causing a significant disease
burden. Two antigenically distinct lineages (“B/Victoria/2/87-like” and “B/Yamagata/16/88 …

The Victoria lineage represented by B/Victoria/2/87 is one of the two major distinctive
haemagglutinin (HA) lineages of influenza B virus, and its recent re-emergence has aroused …

Phylogenetic profiles of the genes coding for the hemagglutinin (HA) protein, nucleoprotein
(NP), matrix (M) protein, and nonstructural (NS) proteins of influenza B viruses isolated from …